Pharming Group N.V.
PHAR
$12.59
-$0.21-1.64%
NASDAQ
| 03/31/2026 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -197.84% | 131.89% | -614.83% | 376.50% | |
| Total Depreciation and Amortization | 34.72% | 4.65% | 41.87% | -33.65% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 26.10% | -47.61% | 0.60% | 1,484.43% | |
| Change in Net Operating Assets | 164.96% | -197.96% | 120.03% | -196.45% | |
| Cash from Operations | -81.77% | 4,961.64% | -97.51% | -4.22% | |
| Capital Expenditure | 11.52% | 54.61% | -116.92% | 64.48% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | 100.00% | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -37,833.04% | -74.67% | 798.23% | -304.83% | |
| Cash from Investing | -188,255.56% | 74.96% | 198.99% | -325.06% | |
| Total Debt Issued | -- | -- | -- | 100.00% | |
| Total Debt Repaid | -848.46% | -49.09% | 52.84% | -54.54% | |
| Issuance of Common Stock | -26.12% | 334.02% | -88.49% | 9,004.35% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 95.60% | 56.17% | -124.48% | -1,212.26% | |
| Cash from Financing | -988.44% | 58.97% | -204.85% | -53.80% | |
| Foreign Exchange rate Adjustments | -172.47% | 211.41% | 163.67% | -454.82% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -818.41% | 521.44% | 190.05% | -142.29% | |